Dosidal · Switzerland

Actemra, Injektionslösung zur subkutanen Anwendung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:63166 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 63166
atc: L04AC07
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2014-09-12
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L04AC07
authorisation_number: 63166
form: LSPA
holder: Roche Pharma (Schweiz) AG
holder_partner_nr: 1000726
it_number: 07.15.0.
name: Actemra, Injektionslösung zur subkutanen Anwendung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
lqYsOeLC1ArAx8PC07PIP1h4HCHkE5xhkLnkcH-NmFNTAJybs046ECZcI1fNMqbAg2tlNVje8p1gc1YM2WAu4w
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:63166 · Same medicine in other markets · Dosidal